What are the ideal properties for functional food peptides with antihypertensive effect? A computational peptidology approach

被引:108
作者
Zhou, Peng [1 ]
Yang, Chao [1 ]
Ren, Yanrong [2 ]
Wang, Congcong [1 ]
Tian, Feifei [3 ]
机构
[1] UESTC, Sch Life Sci & Technol, Ctr Bioinformat COBI, Chengdu 610054, Peoples R China
[2] Chongqing Univ Educ, Dept Biol & Chem Engn, Chongqing 400067, Peoples R China
[3] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China
基金
中国国家自然科学基金;
关键词
Functional food; Peptide; Bioactivity; Computational peptidology; I-CONVERTING-ENZYME; ACE INHIBITORY PEPTIDES; STRUCTURAL REQUIREMENTS; BINDING; VECTOR; PREDICTION; REGRESSION; PROTEINS; SEQUENCE; MODEL;
D O I
10.1016/j.foodchem.2013.05.140
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Peptides with antihypertensive potency have long been attractive to the medical and food communities. However, serving as food additives, rather than therapeutic agents, peptides should have a good taste. In the present study, we explore the intrinsic relationship between the angiotensin I-converting enzyme (ACE) inhibition and bitterness of short peptides in the framework of computational peptidology, attempting to find out the appropriate properties for functional food peptides with satisfactory bioactivities. As might be expected, quantitative structure-activity relationship modeling reveals a significant positive correlation between the ACE inhibition and bitterness of dipeptides, but this correlation is quite modest for tripeptides and, particularly, tetrapeptides. Moreover, quantum mechanics/molecular mechanics analysis of the structural basis and energetic profile involved in ACE-peptide complexes unravels that peptides of up to 4 amino acids long are sufficient to have efficient binding to ACE, and more additional residues do not bring with substantial enhance in their ACE-binding affinity and, thus, antihypertensive capability. All of above, it is coming together to suggest that the tripeptides and tetrapeptides could be considered as ideal candidates for seeking potential functional food additives with both high antihypertensive activity and low bitterness. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2967 / 2973
页数:7
相关论文
共 34 条
[1]  
CHEUNG HS, 1980, J BIOL CHEM, V255, P401
[2]   Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food [J].
De Leo, F. ;
Panarese, S. ;
Gallerani, R. ;
Ceci, L. R. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (31) :3622-3643
[3]   The antihypertensive effect of peptides: A novel alternative to drugs? [J].
Fang Hong ;
Luo Ming ;
Sheng Yi ;
Li Zhanxia ;
Wu Yongquan ;
Liu Chi .
PEPTIDES, 2008, 29 (06) :1062-1071
[4]   Beware of q2! [J].
Golbraikh, A ;
Tropsha, A .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (04) :269-276
[5]   Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis [J].
Hou, TJ ;
McLaughlin, W ;
Lu, B ;
Chen, K ;
Wang, W .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (01) :32-43
[6]   Quantitative structure-activity relationship study of bitter peptides [J].
Kim, Hyun-Ock ;
Li-Chan, Eunice C. Y. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (26) :10102-10111
[7]   INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME BY SYNTHETIC PEPTIDES OF HUMAN BETA-CASEIN [J].
KOHMURA, M ;
NIO, N ;
KUBO, K ;
MINOSHIMA, Y ;
MUNEKATA, E ;
ARIYOSHI, Y .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1989, 53 (08) :2107-2114
[8]   Improved prediction of protein side-chain conformations with SCWRL4 [J].
Krivov, Georgii G. ;
Shapovalov, Maxim V. ;
Dunbrack, Roland L., Jr. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2009, 77 (04) :778-795
[9]   Bitter peptides and bitter taste receptors [J].
Maehashi, K. ;
Huang, L. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (10) :1661-1671
[10]   Antihypertensive peptides from food proteins: a review [J].
Martinez-Maqueda, Daniel ;
Miralles, Beatriz ;
Recio, Isidra ;
Hernandez-Ledesma, Blanca .
FOOD & FUNCTION, 2012, 3 (04) :350-361